We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
A 16 years old female patient admitted to hospital due to fatigue, myalgia, weight loss and night sweats lasting for 10 days. On examination, patient appeared pale with livedo reticularis on lower extremities. On the 2nd day of hospitalization, she developed acute right hemiparesis, dysarthria and right facial droop. Cranial computerized tomography was performed, and it revealed multiple bilateral lesions consistent with acute intracranial hemorrhage. The cranial MRI showed restricted diffusion in the left internal capsule which was in concordance with clinical signs of acute stroke. Past medical history of the patient revealed recurrent attacks of bronchitis. In the laboratory examination, patient had elevated acute phase markers, leukocytosis, mild anemia, thrombocytosis. Further investigations revealed significantly high c-ANCA and proteinase 3 antibody titers, whereas myeloperoxidase antibody was negative. High-resolution computerized tomography revealed lesions in both lungs. A diagnosis of Granulomatosis with Polyangiitis (GPA) was confirmed. high doses of glucocorticoids (30 mg/kg/day for the consecutive 5 days) was given as an induction part of treatment together with pulse dose of cyclophosphamide (1 gr/m2/month for the consecutive 6 months). The rituximab was added to treatment (375 mg/m2/week for the consecutive 4 weeks) since the patient was considered to have life-threating complication of underlying disease. The patient responded promptly with regression of neurological findings, decline in acute phase markers and significantly improvement in patient’s general condition
To determine the long-term efficacy of submucosal corticosteroid injection plus dilatation for subglottic stenosis as a single modality treatment in granulomatosis with polyangiitis and relapsing polychondritis, as compared with idiopathic subglottic stenosis and traumatic subglottic stenosis.
Method:
Patients who underwent dilatation for autoimmune causes were identified. Corticosteroid injection into the submucosa of a stenotic segment was followed by serial dilatation. Definitive improvement was defined as good airway patency for more than 24 months with no further procedures needed. Clinical, demographic and procedural data were recorded.
Results:
Patients (n = 45) were divided into three subglottic stenosis groups: traumatic (n = 24), idiopathic (n = 9) and autoimmune (n = 12). Patients were treated with dilatations, with a median follow-up time of 76 months. Six patients were tracheostomy-dependent. There were no statistical differences in the number of final improvements between autoimmune, idiopathic and traumatic groups, with values of 75, 56 and 71 per cent, respectively. There was no statistical difference between granulomatosis with polyangiitis plus relapsing polychondritis and idiopathic subglottic stenosis in terms of decannulation rates.
Conclusion:
Granulomatosis with polyangiitis and relapsing polychondritis patients have better improvement rates than patients with other subglottic stenosis types.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.